Patent · US Active

Cathepsin C inhibitors

US8841463B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2012
Grant dateSep 23, 2014
Priority date
Expiry dateFeb 9, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D309/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.